Anthem Biosciences Ltd delivered strong December-quarter results, posting ₹4.23 billion in consolidated revenue from operations and a net profit of ₹928.2 million. The performance underscores robust demand in the pharmaceutical and biotech segments, highlighting operational efficiency, margin improvement, and the company’s growing role in India’s life sciences industry.
Show moreStay Ahead – Explore Now! AIA Engineering Posts ₹10.67 Billion Revenue, Net Profit Rises to ₹2.94 Billion
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
